Search Results for agency_names:"Justice Department"

The Department of Justice has announced a 60-day comment period for the proposed reinstatement of the Census of Publicly Funded Forensic Crime Laboratories. This collection aims to acquire updated data on personnel, budgets, and operations of federal, state, and local crime labs across the US. It's part of an effort to understand and improve lab efficiency, following a similar study from 2014. Public comments on the necessity and methodology of this data collection are encouraged until March 15, 2021.

The National Fire Protection Association (NFPA) submitted notifications to the Attorney General and Federal Trade Commission on January 24, 2025, updating its standards development and related activities. This filing aims to limit antitrust plaintiffs to recovering only actual damages under certain conditions, as allowed by the National Cooperative Research and Production Act of 1993. The last such notification from NFPA was made on October 21, 2024, and earlier notices were published in the Federal Register. All information about NFPA's activities can be found at their website, nfpa.org.

In the Federal Register notice titled "Ibrahim Al-Qawaqneh, D.D.S.; Decision and Order," the DEA sought to revoke Dr. Ibrahim Al-Qawaqneh's registration due to his exclusion from federal health care programs after pleading nolo contendere to a charge of offering unlawful Medi-Cal remuneration. Despite being given a chance to defend himself, the DEA found that Dr. Al-Qawaqneh failed to take full responsibility for his actions, which led to doubts about his trustworthiness. Consequently, his DEA Certificate of Registration was revoked to ensure compliance with laws regulating controlled substances.

Patheon Pharmaceuticals Inc. has applied to the Drug Enforcement Administration to become a registered bulk manufacturer of certain controlled substances. The company plans to use these substances as Active Pharmaceutical Ingredients in FDA-approved medications. Anybody interested can submit comments or objections electronically by May 12, 2025, through the Federal eRulemaking Portal. Requests for a hearing regarding this application are also due by the same date.

In a decision by the Drug Enforcement Administration (DEA), Dr. Michael W. Carlton's Certificate of Registration was revoked due to inappropriate prescribing practices. The DEA found that Dr. Carlton issued 40 prescriptions for controlled substances without establishing a proper doctor-patient relationship and without conducting necessary physical exams, which violated federal and Arizona state laws. Dr. Carlton argued that his practice was standard at the outpatient treatment center where he worked, but the DEA's investigation and expert testimony showed that his actions fell below the standard of care. Consequently, the revocation was seen as necessary to protect public interest.

The Drug Enforcement Administration (DEA) issued an Order to Show Cause to Dr. Matthew Okeke, who is based in Nevada. This order proposed revoking his DEA registration because he no longer has a valid state license or authority to handle controlled substances in Nevada. Dr. Okeke did not respond to the order, leading the DEA to proceed with final agency action to revoke his registration. The decision was signed by DEA Administrator Anne Milgram and is set to take effect on January 29, 2025.

The document is a notice from the Department of Justice about changes in the membership of the MLCommons Association, filed according to the National Cooperative Research and Production Act of 1993. New members from various locations, including companies and individuals from the United States, Taiwan, France, the United Kingdom, and Korea, have joined this group research project. The aim of the notification is to ensure that if any antitrust issues arise, damages will be limited to actual damages under certain conditions. The notice also mentions that MLCommons plans to continue updating its membership status as necessary.

The Drug Enforcement Administration (DEA) issued an Order to Show Cause to Soroosh Armandi, D.O., proposing to revoke his DEA registration because he no longer has the authority to handle controlled substances in California. Despite being notified, Dr. Armandi did not request a hearing to contest this action. His California medical license has been revoked, making him ineligible to maintain a DEA registration. As a result, the DEA has decided to revoke his DEA Certificate of Registration and deny any pending applications for renewal or additional registrations in California.

The Department of Justice has lodged a proposed Consent Decree with the court to settle claims against American Zinc Recycling Corp. for environmental law violations at their facility in Palmerton, Pennsylvania. These claims involve federal laws such as the Clean Air Act, Resource Conservation and Recovery Act, Clean Water Act, and Emergency Planning and Community Right-to-Know Act, along with several Pennsylvania state laws. Under the Consent Decree, the company must implement new pollution control measures and pay a $3.3 million penalty, split between the U.S. and Pennsylvania. There is a public comment period on the Consent Decree, during which the document can be reviewed online or requested by mail.

The National Armaments Consortium (NAC) has informed the Attorney General and the Federal Trade Commission about changes in its membership as required by the National Cooperative Research and Production Act of 1993. Several new organizations, such as Acutronic USA Inc. and L3Harris Technologies Power Paragon, Inc., have joined the consortium, while others, including AAI Corporation Inc. and Optimax Systems, Inc., have left. Membership in the consortium remains open, and the NAC continues to update its membership details regularly as per legal requirements. The last notification was filed on October 9, 2020, and announced in the Federal Register on October 30, 2020.